SCHEMBL17875940

SCHEMBL17875940

O=S1(=O)Cc2cc(-c3ccc4c(c3)oc3ccccc34)ccc2-c2cc(-c3cc(-c4ccccc4)nc(-c4ccccc4)c3)ccc2C1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.34
MMP12 P39900 1/20 0.34
MMP13 P45452 1/20 0.34
KDM4E B2RXH2 7/20 0.33
MAPT P10636 5/20 0.33
ALDH1A1 P00352 3/20 0.33
HPGD P15428 3/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
MAPK1 P28482 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
DHODH Q02127 1/20 0.32
SMN1; SMN2 Q16637 3/20 0.31
LMNA P02545 3/20 0.31
GAA P10253 2/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875973 1.00 HCRTR1 (0.34) HCRTR1MMP12MMP13KDM4EMAPT
SCHEMBL17875996 0.96 HCRTR1 (0.37) HCRTR1MMP12MMP13KDM4EMAPT
SCHEMBL17875947 0.94 PLA2G2A (0.35) KDM4EMAPTALDH1A1HPGDMEN1
SCHEMBL17875979 0.94 PLA2G2A (0.35) KDM4EMAPTALDH1A1HPGDMEN1
SCHEMBL17875966 0.91 MMP12 (0.39) HCRTR1MMP12MMP13KDM4EMAPT
SCHEMBL17875936 0.91 MMP12 (0.39) HCRTR1MMP12MMP13KDM4EMAPT
SCHEMBL17876006 0.89 PLA2G2A (0.38) KDM4EMAPTALDH1A1HPGDMEN1
SCHEMBL17875933 0.89 MEN1 (0.40) HCRTR1MMP12MMP13KDM4EMAPT
SCHEMBL17875956 0.89 PRKDC (0.32) KDM4EMAPTALDH1A1HPGDL3MBTL1
SCHEMBL17875971 0.89 PRKDC (0.32) KDM4EMAPTALDH1A1HPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 HCRTR1 214/4885MMP12 4056/4885MMP13 3950/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 HCRTR1 214/4885MMP12 4056/4885MMP13 3950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.